FdaApplication
ANDA 205581
Identifiers
- fda_app_no: ANDA205581
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2016-12-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPTIFIBATIDE | EPTIFIBATIDE | 75MG/100ML | INJECTABLE;INJECTION |
| EPTIFIBATIDE | EPTIFIBATIDE | 2MG/ML | INJECTABLE;INJECTION |
2 products